SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific informs about updates

19 Nov 2025 Evaluate
Sequent Scientific has informed that in furtherance of the previous disclosures dated September 26, 2024, January 21, 2025, May 26, 2025, August 30, 2025, and November 18, 2025 the written order of the National Company Law Tribunal, Hyderabad bench (Hon’ble Tribunal) dated November 18, 2025, sanctioning the Scheme (Order), has been uploaded on the website of the Hon’ble Tribunal today, November 19, 2025. A copy of the Order is annexed and can also be accessed on the website of the Hon’ble Tribunal at this link. Certified copy of the order is awaited.

The above information is a part of company’s filings submitted to BSE.

Viyash Scientific Share Price

208.90 0.05 (0.02%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×